Table V.
Literature review: randomized controlled trials
| Author, year | Group (n) | Intervention | Outcomes | Conclusion (statistically significant difference between/among groups) | ||
|---|---|---|---|---|---|---|
| Staple-line bleeding | Stenosis | Gastric leak | ||||
| Carandina et al. 2016 [16] | A (150) | No SLR | 1 | 2 | 3 | No |
| B (150) | SLR with fibrin glue | 2 | 2 | 4 | ||
| C (150) | Imbricating absorbable running suture | 1 | 1 | 3 | ||
| D (150) | Barbed running suture | 1 | 2 | 4 | ||
| Aggarwal et al. 2013 [13] | A (30) | Running suture | 0 | 0 | 0 | No |
| B (30) | No SLR | 1 | 0 | 2 | ||
| Gentileschi et al. 2012 [14] | A (35) | Running suture | 1 | 0 | 1 | No |
| B (34) | GORE SEAMGUARDa | 1 | 0 | 0 | ||
| C (33) | FLOSEALb | 0 | 0 | 1 | ||
| Musella et al. 2011 [17] | A (50) | 3-0 polypropylene running suture | 4 | 4 | 1 | Bleeding, leaks: No Strictures: Yes |
| B (50) | No SLR | 2 | 0 | 2 | ||
| Albanopoulos et al. 2012 [18] | A (48) | Gore seamguarda | 1 | NA | 2 | No |
| B (42) | 2-0 PDS running suture | 0 | NA | 0 | ||
| Dapri et al. 2010 [15] | A (25) | No SLR | NA | NA | 1 | No |
| B (25) | GORE SEAMGUARDa | NA | NA | 2 | ||
| C (25) | Running suture | NA | NA | 1 | ||
| Present study | Clipping (50) | No SLR (clipping) | 2 | 1 | 1 | No |
| Oversewing (50) | 3-0 Biosync continuous extraserosal invaginating suture | 0 | 0 | 0 | ||
a
Gore Medical/W.L. Gore & Associates, Inc., Flagstaff, AZ, USA.
b
Baxter Healthcare Corp., Deerfield, IL, USA.
cCovidien/Medtronic, Inc., Mansfield, MA, USA. SLR – staple-line reinforcement.